Coronavirus (COVID-19)
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. COVID-19 is a disease caused by SARS-CoV-2 that can trigger what doctors call a respiratory tract infection. It can affect your upper respiratory tract (sinuses, nose, and throat) or lower respiratory tract (windpipe and lungs).
- Sortness of breath
- Trouble Breathing
Related Conference of Coronavirus (COVID-19)
December 01-02, 2021
13th International Conference on Chronic Obstructive Pulmonary Disease Conference
Barcelona, Spain
October 10-11, 2022
International Conference on Respirology, Lung & Chest Physicians
Vancouver, Canada
Coronavirus (COVID-19) Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Abnormalities in breathing regulation - LUNG DISEASES 2021 (UK)
- Alpha 1 Antitrypsin Deficiency & COPD - Lung Diseases 2022 (Belgium)
- Applications of Probiotics in Health and Diseases - Probiotics 2022 (Japan)
- Asthma - Lung Diseases 2022 (Belgium)
- Asthma and Allergy - PULMONOLOGY 2022 (Japan)
- Asthma and COPD - COPD 2021 (Spain)
- Baby Foods - Probiotics 2022 (Japan)
- Betterment of Lung Abscess - LUNG DISEASES 2021 (UK)
- Biological Effects of Probiotics - Probiotics 2022 (Japan)
- Cardio Pulmonary Disorders - Respiratory 2022 (France)
- Cardio Pulmonary Disorders - LUNG DISEASES 2021 (UK)
- Cardiopulmonary Disorders - Lung Diseases 2022 (Belgium)
- Cardiopulmonary Disorders - PULMONOLOGY 2022 (Japan)
- Chronic Obstructive Pulmonary Disease - Respiratory 2022 (France)
- Chronic Obstructive Pulmonary Disease - Lung Diseases 2022 (Belgium)
- Chronic Obstructive Pulmonary Disease - PULMONOLOGY 2022 (Japan)
- Chronic Obstructive Pulmonary Disease - COPD 2021 (Spain)
- Clinical management of severe acute respiratory infection - Lung Diseases 2022 (Belgium)
- CO-Morbidities in COPD - LUNG DISEASES 2021 (UK)
- Co-Morbidities of COPD - COPD 2021 (Spain)
- COPD and Cardiovascular Diseases - COPD 2021 (Spain)
- COPD chronic obstructive pulmonary disease - LUNG DISEASES 2021 (UK)
- COPD Complications - COPD 2021 (Spain)
- COPD Exacerbations - LUNG DISEASES 2021 (UK)
- COPD Exacerbations - COPD 2021 (Spain)
- COPD Pathogenesis - COPD 2021 (Spain)
- COPD Therapeutics - COPD 2021 (Spain)
- COPD: Sign and Symptoms - COPD 2021 (Spain)
- COVID-19 and Asthma - Respiratory 2022 (France)
- COVID-19 and Respiratory System - Respiratory 2022 (France)
- COVID-19 Treatment and Recovery - Lung Diseases 2022 (Belgium)
- Covid19 Vaccine and Lung Immunopathology - Lung Diseases 2022 (Belgium)
- Cystic Fibrosis - Lung Diseases 2022 (Belgium)
- Cystic Fibrosis - PULMONOLOGY 2022 (Japan)
- Depression and anxiety in COPD - Lung Diseases 2022 (Belgium)
- Depression and anxiety in COPD - COPD 2021 (Spain)
- Diagnosis and Treatment of COPD - Lung Diseases 2022 (Belgium)
- Digital Health in Respiratory Care - Lung Diseases 2022 (Belgium)
- Drug Discovery of COPD - COPD 2021 (Spain)
- Effect of COVID-19 on Lungs - Lung Diseases 2022 (Belgium)
- Effect of Thoracic tumors on lungs - LUNG DISEASES 2021 (UK)
- Epidemiology of COPD - COPD 2021 (Spain)
- Food Sensor - Probiotics 2022 (Japan)
- Functional Foods - Probiotics 2022 (Japan)
- Genetic risk factor of COPD - Lung Diseases 2022 (Belgium)
- Genetic risk factor of COPD - COPD 2021 (Spain)
- Genomics of Probiotics, Prebiotics - Probiotics 2022 (Japan)
- Hantavirus Pulmonary Syndrome (HPS) - LUNG DISEASES 2021 (UK)
- Idiopathic Pulmonary Fibrosis - Respiratory 2022 (France)
- Idiopathic Pulmonary Fibrosis - Lung Diseases 2022 (Belgium)
- Idiopathic Pulmonary Fibrosis - PULMONOLOGY 2022 (Japan)
- Idiopathic Pulmonary Fibrosis - LUNG DISEASES 2021 (UK)
- Impact of COVID-19 on lungs - LUNG DISEASES 2021 (UK)
- Innate Immunity and Lung Fibrosis - Lung Diseases 2022 (Belgium)
- Interstitial Lung Disease - LUNG DISEASES 2021 (UK)
- Interstitial lung disease - Respiratory 2022 (France)
- Interstitial lung disease - PULMONOLOGY 2022 (Japan)
- Investigational Drugs and Other Therapies in the treatment of Respiratory Disease - Lung Diseases 2022 (Belgium)
- Knowledge on Chronic bronchitis and Pulmonary Hypertension - LUNG DISEASES 2021 (UK)
- Lung cancer - Respiratory 2022 (France)
- Lung cancer - Lung Diseases 2022 (Belgium)
- Lung cancer - COPD 2021 (Spain)
- Lung cancer diagnosis & treatment - LUNG DISEASES 2021 (UK)
- Lung Cancer Diagnosis & Treatment - Lung Diseases 2022 (Belgium)
- Lung Diseases - PULMONOLOGY 2022 (Japan)
- Lung Transplantation - LUNG DISEASES 2021 (UK)
- Lung transplantation - Respiratory 2022 (France)
- Mechanism of Probiotics - Probiotics 2022 (Japan)
- Mediators of Lung damage and Dysfunction in Tuberculosis - LUNG DISEASES 2021 (UK)
- Microbiome and Probiotics - Probiotics 2022 (Japan)
- Obstructive sleep apnea - Respiratory 2022 (France)
- Obstructive sleep apnea - PULMONOLOGY 2022 (Japan)
- Occupational & Environmental Lung Disease - LUNG DISEASES 2021 (UK)
- Occupational lung diseases - Respiratory 2022 (France)
- Occurrence of Pneumonia in lungs - LUNG DISEASES 2021 (UK)
- Pathology and Clinical Management of COPD - Lung Diseases 2022 (Belgium)
- Pathophysiology of COPD - COPD 2021 (Spain)
- Pediatric Pulmonary, Critical care and Sleep - COPD 2021 (Spain)
- Pediatric Pulmonology & Critical care - PULMONOLOGY 2022 (Japan)
- Pneumonia - Lung Diseases 2022 (Belgium)
- Pneumonia - Respiratory 2022 (France)
- Prebiotics - Probiotics 2022 (Japan)
- Prevention and Control of Respiratory Diseases - LUNG DISEASES 2021 (UK)
- Probiotic and Digestive Health - Probiotics 2022 (Japan)
- Probiotic industrial products - Probiotics 2022 (Japan)
- Probiotic industrial products - Probiotics 2022 (Japan)
- Probiotic Microorganism - Probiotics 2022 (Japan)
- Probiotic Nutrition - Probiotics 2022 (Japan)
- Probiotics - Probiotics 2022 (Japan)
- Probiotics Delivery Systems - Probiotics 2022 (Japan)
- Pulmonary Diseases and therapeutics - PULMONOLOGY 2022 (Japan)
- Pulmonary diseases treatment and therapies - COPD 2021 (Spain)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2022 (France)
- Pulmonary Hypertension - PULMONOLOGY 2022 (Japan)
- Pulmonary Hypertension - Respiratory 2022 (France)
- Pulmonary Hypertension - COPD 2021 (Spain)
- Pulmonary Rehabilitation - Lung Diseases 2022 (Belgium)
- Pulmonary Rehabilitation - Respiratory 2022 (France)
- Pulmonary Rehabilitation - PULMONOLOGY 2022 (Japan)
- Pulmonary, Critical care and Sleep - LUNG DISEASES 2021 (UK)
- Relationship between Pancreatitis and Lung diseases - LUNG DISEASES 2021 (UK)
- Respiratory Diseases - Lung Diseases 2022 (Belgium)
- Respiratory tract infections - PULMONOLOGY 2022 (Japan)
- Self-Management and Prevention of COPD - COPD 2021 (Spain)
- Severe Acute Respiratory Syndrome (SARS) - Lung Diseases 2022 (Belgium)
- Sleep apnea - Lung Diseases 2022 (Belgium)
- Strains of Probiotics - Probiotics 2022 (Japan)
- Tuberculosis - Lung Diseases 2022 (Belgium)
- Tuberculosis - Respiratory 2022 (France)
- Tuberculosis - PULMONOLOGY 2022 (Japan)
- Types of COPD - COPD 2021 (Spain)